Korean Circ J.  2015 Nov;45(6):469-472. 10.4070/kcj.2015.45.6.469.

Prevalence of Gastrointestinal Diseases and Treatment Status in Noncardiac Chest Pain Patients

• Park SH
• Choi JY
• Park EJ
• Lee JJ
• Lee S
• Na JO
• Choi CU
• Lim HE
• Kim JW
• Kim EJ
• Rha SW
• Seo HS
• Oh DJ
• Park CG

• KMID: 2223784
• DOI: http://doi.org/10.4070/kcj.2015.45.6.469

Abstract

BACKGROUND AND OBJECTIVES
We evaluated the prevalence of gastroesophageal reflux diseases (GERD) in noncardiac chest pain (NCCP) patients, risk factors for GERD, and status of prescriptions for GERD in Korean population.
SUBJECTS AND METHODS
This was a retrospective non-interventional observational nation-wide 45-center study. Patients with a normal coronary angiogram (CAG) and upper gastroendoscopy within 2 years after CAG were enrolled. The prevalence of GERD was examined. Other gastrointestinal diseases including peptic ulcer diseases or gastritis were also examined. Risk factors for GERD were compared between the GERD group and non-GERD group. The ratio of patients medicated for gastrointestinal diseases (antacids or proton-pump inhibitor) was also examined.
RESULTS
Nine hundred four patients were enrolled. Among the NCCP patients, GERD was present in 436 (48.2%), peptic ulcer disease in 154 patients (17.0%), and gastritis in 659 (72.9%). There was no difference in risk factors for GERD between the GERD and non-GERD patients. Medications for GERD and other gastrointestinal diseases were prescribed in 742 (82.1%) patients.
CONCLUSION
GERD was common (42.8%) in Korean NCCP patients and most (82.1%) received the prescription of gastrointestinal medications. No differences were evident in risk factors between GERD and non-GERD patients.

Keyword

Chest pain; Gastroesophageal reflux

MeSH Terms

Chest Pain*
Gastritis
Gastroesophageal Reflux
Gastrointestinal Diseases*
Humans
Peptic Ulcer
Prescriptions
Prevalence*
Retrospective Studies
Risk Factors
Thorax*

Reference

1. Eslick GD, Jones MP, Talley NJ. Non-cardiac chest pain: prevalence, risk factors, impact and consulting--a population-based study. Aliment Pharmacol Ther. 2003; 17:1115–1124.

2. Wong WM, Lai KC, Lau CP, et al. Upper gastrointestinal evaluation of Chinese patients with non-cardiac chest pain. Aliment Pharmacol Ther. 2002; 16:465–471.

3. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. Global Consensus Group. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006; 101:1900–1920. quiz 1943

4. Hollerbach S, Bulat R, May A, et al. Abnormal cerebral processing of oesophageal stimuli in patients with noncardiac chest pain (NCCP). Neurogastroenterol Motil. 2000; 12:555–565.

5. Fass R, Achem SR. Noncardiac chest pain: epidemiology, natural course and pathogenesis. J Neurogastroenterol Motil. 2011; 17:110–123.

6. Wong WM. Use of proton pump inhibitor as a diagnostic test in NCCP. J Gastroenterol Hepatol. 2005; 20:Suppl. S14–S17.

7. Choi TH, Lee DH, Jeong YJ, et al. The clinical characteristics of noncardiac chest pain and treatment response in non-erosive reflux disease (NERD). Korean J Med. 2010; 79:16–22.

8. Kim N, Lee SW, Cho SI, et al. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea. Aliment Pharmacol Ther. 2008; 27:173–185.

9. Lampe FC, Whincup PH, Wannamethee SG, Ebrahim S, Walker M, Shaper AG. Chest pain on questionnaire and prediction of major ischaemic heart disease events in men. Eur Heart J. 1998; 19:63–73.

10. Gill RS, Collins JS, Talley NJ. Management of noncardiac chest pain in women. Womens Health (Lond Engl). 2012; 8:131–143. quiz 144-5

11. Lee SH, Choi MG, Park SH, et al. The clinical spectrum of gastroesphageal reflux disease in Korea. Korean J Gastrointest Motil. 2000; 6:1–10.

12. Wong WM, Lam KF, Cheng C, et al. Population based study of noncardiac chest pain in southern Chinese: prevalence, psychosocial factors and health care utilization. World J Gastroenterol. 2004; 10:707–712.

13. Carmin CN, Ownby RL, Wiegartz PS, Kondos GT. Women and non-cardiac chest pain: gender differences in symptom presentation. Arch Womens Ment Health. 2008; 11:287–293.

14. Cremonini F, Wise J, Moayyedi P, Talley NJ. Diagnostic and therapeutic use of proton pump inhibitors in non-cardiac chest pain: a metaanalysis. Am J Gastroenterol. 2005; 100:1226–1232.

15. Faybush EM, Fass R. Gastroesophageal reflux disease in noncardiac chest pain. Gastroenterol Clin North Am. 2004; 33:41–54.